Doxycycline hyclate 100 MG VLS
Ended Awarded
- Contract number
- SPE2D325F214X
- Awardee
-
Hikma Pharmaceuticals USA Inc. UEI NQJ5E87TKNB1 Part of Hikma Specialty USA Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $42,921
Award facts
- Contract value 100% obligated
- $42,921.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Berkeley Heights, NJ 07922, USA
Award details come from SAM.gov/FPDS.
About this award
Hikma Pharmaceuticals USA Inc. (formerly West-Ward Pharmaceuticals) was awarded a delivery order on July 14, 2025, for the supply of Doxycycline Hyclate 100 mg with a ceiling value of $42,921.09. This firm fixed-price delivery order, which is expected to be completed by July 15, 2025, was issued without a small business set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. The product will be delivered to Berkeley Heights, New Jersey, supporting the pharmaceutical supply requirements of the Department of Defense and military healthcare systems.
This delivery order is likely issued under one of Hikma's existing Indefinite Delivery Vehicles, specifically the company's $216 million multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs or related pharmaceutical supply agreements. Hikma has established itself as a critical supplier of generic injectable and non-injectable pharmaceutical products to federal healthcare systems, with a track record of delivering essential medications including doxycycline, naloxone, ketamine, and other critical drugs to military treatment facilities and veteran healthcare networks. The company is registered in the System for Award Management and maintains significant pharmaceutical supply contracts supporting medical readiness across defense and veterans' healthcare systems.
Quick answers
Who was awarded contract SPE2D325F214X?
SPE2D325F214X was awarded to Hikma Pharmaceuticals USA Inc. by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2D325F214X worth?
The government has obligated $42,921 on SPE2D325F214X.
Is contract SPE2D325F214X an order under another contract?
Yes. SPE2D325F214X is a delivery order under SPE2D020D0006, an indefinite delivery contract.
Was contract SPE2D325F214X competed?
The extent of competition for SPE2D325F214X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award